0
  • Category
  • Region
U.S. (TOLL FREE)
+1 (315) 215-3225
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Argatroban Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
Published Date: March 2025
|
Report Code: QYRE-Auto-16160
Home | Market Reports | Health| Pharmacy
Global Argatroban Market Insights and Forecast to 2028
BUY CHAPTERS

Global Argatroban Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Code: QYRE-Auto-16160
Report
March 2025
Pages:80
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Argatroban Sales Market Size

The global Argatroban market size was US$ 56.2 million in 2024 and is forecast to a readjusted size of US$ 37.8 million by 2031 with a CAGR of -5.6% during the forecast period 2025-2031.

Argatroban Sales Market

Argatroban Sales Market

Argatroban is a synthetic direct thrombin inhibitor and the chemical name is 1-[5- [(aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]amino]pentyl]-4-methyl-2-piperidinecarboxylic acid, monohydrate. Argatroban has 4 asymmetric carbons. One of the asymmetric carbons has an R configuration (stereoisomer Type I) and an S configuration (stereoisomer Type II). Argatroban consists of a mixture of R and S stereoisomers at a ratio of approximately 65:35.
Global Argatroban key players include Mitsubishi Tanabe Pharma, Pfizer, Inc, Teva Pharmaceutical Industries Ltd, SANDOZ, etc. Global top four manufacturers hold a share nearly 60%.
Japan is the largest market, with a share about 35%, followed by Europe, and USA, both have a share about 55 percent.
In terms of product, Argatroban Injection is the largest segment, with a share over 70%. And in terms of application, the largest application is Heparin-induced thrombocytopenia (HIT), followed by Percutaneous Coronary Intervention, Cerebral arterial thrombosis.
The global Argatroban market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation

Scope of Argatroban Sales Market Report

Report Metric Details
Report Name Argatroban Sales Market
Forecasted market size in 2031 US$ 37.8 million
Forecasted years 2025 - 2031
By Type: (Dominant Segment vs High-Margin Innovation)
  • Argatroban Powder
  • Argatroban Injection
By Application: (Core Demand Driver vs Emerging Opportunity)
  • Heparin-induced Thrombocytopenia (HIT)
  • Percutaneous Coronary Intervention
  • Cerebral Arterial Thrombosis
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company: Pfizer, Inc, SANDOZ, GlaxoSmithKline Plc, fresenius-kabi, Eagle Pharmaceuticals, Inc, Mitsubishi Tanabe Pharma, Teva Pharmaceutical Industries Ltd, WEST-WARD,INC
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
  • Chapter 2: Quantitative analysis of Argatroban market size and growth potential at global, regional, and country levels.
  • Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
  • Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Argatroban Injection in China).
  • Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Percutaneous Coronary Intervention in India).
  • Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
  • Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
  • Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 9: Actionable conclusions and strategic recommendations.
  • Why This Report?
  • This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:
  • - Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).
  • - Product Portfolio Optimization: Align offerings with regional preferences (e.g., Argatroban Powder dominance in Europe vs. Argatroban Injection demand in MEA).
  • - Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.

FAQ for this report

What is the Argatroban Sales Market size in 2031?

Ans: The Argatroban Sales Market size in 2031 will be US$ 37.8 million.

What is the market share of major companies in Argatroban Sales Market?

Ans: Global top four manufacturers hold a share nearly 60%.

What is the Argatroban Sales Market share by type?

Ans: In terms of product, Argatroban Injection is the largest segment, with a share over 70%.

Who are the main players in the Argatroban Sales Market report?

Ans: The main players in the Argatroban Sales Market are Pfizer, Inc, SANDOZ, GlaxoSmithKline Plc, fresenius-kabi, Eagle Pharmaceuticals, Inc, Mitsubishi Tanabe Pharma, Teva Pharmaceutical Industries Ltd, WEST-WARD,INC

What are the Application segmentation covered in the Argatroban Sales Market report?

Ans: The Applications covered in the Argatroban Sales Market report are Heparin-induced Thrombocytopenia (HIT), Percutaneous Coronary Intervention, Cerebral Arterial Thrombosis

What are the Type segmentation covered in the Argatroban Sales Market report?

Ans: The Types covered in the Argatroban Sales Market report are Argatroban Powder, Argatroban Injection

1 Market Overview
1.1 Argatroban Product Scope
1.2 Argatroban by Type
1.2.1 Global Argatroban Sales by Type (2020 & 2024 & 2031)
1.2.2 Argatroban Powder
1.2.3 Argatroban Injection
1.3 Argatroban by Application
1.3.1 Global Argatroban Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Heparin-induced Thrombocytopenia (HIT)
1.3.3 Percutaneous Coronary Intervention
1.3.4 Cerebral Arterial Thrombosis
1.4 Global Argatroban Market Estimates and Forecasts (2020-2031)
1.4.1 Global Argatroban Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Argatroban Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Argatroban Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Argatroban Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Argatroban Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Argatroban Sales Market Share by Region (2020-2025)
2.2.2 Global Argatroban Revenue Market Share by Region (2020-2025)
2.3 Global Argatroban Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Argatroban Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Argatroban Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Argatroban Market Size and Prospective (2020-2031)
2.4.2 Europe Argatroban Market Size and Prospective (2020-2031)
2.4.3 China Argatroban Market Size and Prospective (2020-2031)
2.4.4 Japan Argatroban Market Size and Prospective (2020-2031)
2.4.5 Israel Argatroban Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Argatroban Historic Market Review by Type (2020-2025)
3.1.1 Global Argatroban Sales by Type (2020-2025)
3.1.2 Global Argatroban Revenue by Type (2020-2025)
3.1.3 Global Argatroban Price by Type (2020-2025)
3.2 Global Argatroban Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Argatroban Sales Forecast by Type (2026-2031)
3.2.2 Global Argatroban Revenue Forecast by Type (2026-2031)
3.2.3 Global Argatroban Price Forecast by Type (2026-2031)
3.3 Different Types Argatroban Representative Players
4 Global Market Size by Application
4.1 Global Argatroban Historic Market Review by Application (2020-2025)
4.1.1 Global Argatroban Sales by Application (2020-2025)
4.1.2 Global Argatroban Revenue by Application (2020-2025)
4.1.3 Global Argatroban Price by Application (2020-2025)
4.2 Global Argatroban Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Argatroban Sales Forecast by Application (2026-2031)
4.2.2 Global Argatroban Revenue Forecast by Application (2026-2031)
4.2.3 Global Argatroban Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Argatroban Application
5 Competition Landscape by Players
5.1 Global Argatroban Sales by Players (2020-2025)
5.2 Global Top Argatroban Players by Revenue (2020-2025)
5.3 Global Argatroban Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Argatroban as of 2024)
5.4 Global Argatroban Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Argatroban, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Argatroban, Product Type & Application
5.7 Global Key Manufacturers of Argatroban, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Argatroban Sales by Company
6.1.1.1 North America Argatroban Sales by Company (2020-2025)
6.1.1.2 North America Argatroban Revenue by Company (2020-2025)
6.1.2 North America Argatroban Sales Breakdown by Type (2020-2025)
6.1.3 North America Argatroban Sales Breakdown by Application (2020-2025)
6.1.4 North America Argatroban Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Argatroban Sales by Company
6.2.1.1 Europe Argatroban Sales by Company (2020-2025)
6.2.1.2 Europe Argatroban Revenue by Company (2020-2025)
6.2.2 Europe Argatroban Sales Breakdown by Type (2020-2025)
6.2.3 Europe Argatroban Sales Breakdown by Application (2020-2025)
6.2.4 Europe Argatroban Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Argatroban Sales by Company
6.3.1.1 China Argatroban Sales by Company (2020-2025)
6.3.1.2 China Argatroban Revenue by Company (2020-2025)
6.3.2 China Argatroban Sales Breakdown by Type (2020-2025)
6.3.3 China Argatroban Sales Breakdown by Application (2020-2025)
6.3.4 China Argatroban Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Argatroban Sales by Company
6.4.1.1 Japan Argatroban Sales by Company (2020-2025)
6.4.1.2 Japan Argatroban Revenue by Company (2020-2025)
6.4.2 Japan Argatroban Sales Breakdown by Type (2020-2025)
6.4.3 Japan Argatroban Sales Breakdown by Application (2020-2025)
6.4.4 Japan Argatroban Major Customer
6.4.5 Japan Market Trend and Opportunities
6.5 Israel Market: Players, Segments, Downstream and Major Customers
6.5.1 Israel Argatroban Sales by Company
6.5.1.1 Israel Argatroban Sales by Company (2020-2025)
6.5.1.2 Israel Argatroban Revenue by Company (2020-2025)
6.5.2 Israel Argatroban Sales Breakdown by Type (2020-2025)
6.5.3 Israel Argatroban Sales Breakdown by Application (2020-2025)
6.5.4 Israel Argatroban Major Customer
6.5.5 Israel Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Pfizer, Inc
7.1.1 Pfizer, Inc Company Information
7.1.2 Pfizer, Inc Business Overview
7.1.3 Pfizer, Inc Argatroban Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Pfizer, Inc Argatroban Products Offered
7.1.5 Pfizer, Inc Recent Development
7.2 SANDOZ
7.2.1 SANDOZ Company Information
7.2.2 SANDOZ Business Overview
7.2.3 SANDOZ Argatroban Sales, Revenue and Gross Margin (2020-2025)
7.2.4 SANDOZ Argatroban Products Offered
7.2.5 SANDOZ Recent Development
7.3 GlaxoSmithKline Plc
7.3.1 GlaxoSmithKline Plc Company Information
7.3.2 GlaxoSmithKline Plc Business Overview
7.3.3 GlaxoSmithKline Plc Argatroban Sales, Revenue and Gross Margin (2020-2025)
7.3.4 GlaxoSmithKline Plc Argatroban Products Offered
7.3.5 GlaxoSmithKline Plc Recent Development
7.4 fresenius-kabi
7.4.1 fresenius-kabi Company Information
7.4.2 fresenius-kabi Business Overview
7.4.3 fresenius-kabi Argatroban Sales, Revenue and Gross Margin (2020-2025)
7.4.4 fresenius-kabi Argatroban Products Offered
7.4.5 fresenius-kabi Recent Development
7.5 Eagle Pharmaceuticals, Inc
7.5.1 Eagle Pharmaceuticals, Inc Company Information
7.5.2 Eagle Pharmaceuticals, Inc Business Overview
7.5.3 Eagle Pharmaceuticals, Inc Argatroban Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Eagle Pharmaceuticals, Inc Argatroban Products Offered
7.5.5 Eagle Pharmaceuticals, Inc Recent Development
7.6 Mitsubishi Tanabe Pharma
7.6.1 Mitsubishi Tanabe Pharma Company Information
7.6.2 Mitsubishi Tanabe Pharma Business Overview
7.6.3 Mitsubishi Tanabe Pharma Argatroban Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Mitsubishi Tanabe Pharma Argatroban Products Offered
7.6.5 Mitsubishi Tanabe Pharma Recent Development
7.7 Teva Pharmaceutical Industries Ltd
7.7.1 Teva Pharmaceutical Industries Ltd Company Information
7.7.2 Teva Pharmaceutical Industries Ltd Business Overview
7.7.3 Teva Pharmaceutical Industries Ltd Argatroban Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Teva Pharmaceutical Industries Ltd Argatroban Products Offered
7.7.5 Teva Pharmaceutical Industries Ltd Recent Development
7.8 WEST-WARD,INC
7.8.1 WEST-WARD,INC Company Information
7.8.2 WEST-WARD,INC Business Overview
7.8.3 WEST-WARD,INC Argatroban Sales, Revenue and Gross Margin (2020-2025)
7.8.4 WEST-WARD,INC Argatroban Products Offered
7.8.5 WEST-WARD,INC Recent Development
8 Argatroban Manufacturing Cost Analysis
8.1 Argatroban Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Argatroban
8.4 Argatroban Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Argatroban Distributors List
9.3 Argatroban Customers
10 Argatroban Market Dynamics
10.1 Argatroban Industry Trends
10.2 Argatroban Market Drivers
10.3 Argatroban Market Challenges
10.4 Argatroban Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
List of Tables
 Table 1. Global Argatroban Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
 Table 2. Global Argatroban Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
 Table 3. Global Market Argatroban Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
 Table 4. Global Argatroban Sales (g) by Region (2020-2025)
 Table 5. Global Argatroban Sales Market Share by Region (2020-2025)
 Table 6. Global Argatroban Revenue (US$ Million) Market Share by Region (2020-2025)
 Table 7. Global Argatroban Revenue Share by Region (2020-2025)
 Table 8. Global Argatroban Sales (g) Forecast by Region (2026-2031)
 Table 9. Global Argatroban Sales Market Share Forecast by Region (2026-2031)
 Table 10. Global Argatroban Revenue (US$ Million) Forecast by Region (2026-2031)
 Table 11. Global Argatroban Revenue Share Forecast by Region (2026-2031)
 Table 12. Global Argatroban Sales by Type (g) & (2020-2025)
 Table 13. Global Argatroban Sales Share by Type (2020-2025)
 Table 14. Global Argatroban Revenue by Type (US$ Million) & (2020-2025)
 Table 15. Global Argatroban Price by Type (USD/g) & (2020-2025)
 Table 16. Global Argatroban Sales by Type (g) & (2026-2031)
 Table 17. Global Argatroban Revenue by Type (US$ Million) & (2026-2031)
 Table 18. Global Argatroban Price by Type (USD/g) & (2026-2031)
 Table 19. Representative Players of Each Type
 Table 20. Global Argatroban Sales by Application (g) & (2020-2025)
 Table 21. Global Argatroban Sales Share by Application (2020-2025)
 Table 22. Global Argatroban Revenue by Application (US$ Million) & (2020-2025)
 Table 23. Global Argatroban Price by Application (USD/g) & (2020-2025)
 Table 24. Global Argatroban Sales by Application (g) & (2026-2031)
 Table 25. Global Argatroban Revenue Market Share by Application (US$ Million) & (2026-2031)
 Table 26. Global Argatroban Price by Application (USD/g) & (2026-2031)
 Table 27. New Sources of Growth in Argatroban Application
 Table 28. Global Argatroban Sales by Company (g) & (2020-2025)
 Table 29. Global Argatroban Sales Share by Company (2020-2025)
 Table 30. Global Argatroban Revenue by Company (US$ Million) & (2020-2025)
 Table 31. Global Argatroban Revenue Share by Company (2020-2025)
 Table 32. Global Argatroban by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Argatroban as of 2024)
 Table 33. Global Market Argatroban Average Price by Company (USD/g) & (2020-2025)
 Table 34. Global Key Manufacturers of Argatroban, Manufacturing Sites & Headquarters
 Table 35. Global Key Manufacturers of Argatroban, Product Type & Application
 Table 36. Global Key Manufacturers of Argatroban, Date of Enter into This Industry
 Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 38. North America Argatroban Sales by Company (2020-2025) & (g)
 Table 39. North America Argatroban Sales Market Share by Company (2020-2025)
 Table 40. North America Argatroban Revenue by Company (2020-2025) & (US$ Million)
 Table 41. North America Argatroban Revenue Market Share by Company (2020-2025)
 Table 42. North America Argatroban Sales by Type (2020-2025) & (g)
 Table 43. North America Argatroban Sales Market Share by Type (2020-2025)
 Table 44. North America Argatroban Sales by Application (2020-2025) & (g)
 Table 45. North America Argatroban Sales Market Share by Application (2020-2025)
 Table 46. Europe Argatroban Sales by Company (2020-2025) & (g)
 Table 47. Europe Argatroban Sales Market Share by Company (2020-2025)
 Table 48. Europe Argatroban Revenue by Company (2020-2025) & (US$ Million)
 Table 49. Europe Argatroban Revenue Market Share by Company (2020-2025)
 Table 50. Europe Argatroban Sales by Type (2020-2025) & (g)
 Table 51. Europe Argatroban Sales Market Share by Type (2020-2025)
 Table 52. Europe Argatroban Sales by Application (2020-2025) & (g)
 Table 53. Europe Argatroban Sales Market Share by Application (2020-2025)
 Table 54. China Argatroban Sales by Company (2020-2025) & (g)
 Table 55. China Argatroban Sales Market Share by Company (2020-2025)
 Table 56. China Argatroban Revenue by Company (2020-2025) & (US$ Million)
 Table 57. China Argatroban Revenue Market Share by Company (2020-2025)
 Table 58. China Argatroban Sales by Type (2020-2025) & (g)
 Table 59. China Argatroban Sales Market Share by Type (2020-2025)
 Table 60. China Argatroban Sales by Application (2020-2025) & (g)
 Table 61. China Argatroban Sales Market Share by Application (2020-2025)
 Table 62. Japan Argatroban Sales by Company (2020-2025) & (g)
 Table 63. Japan Argatroban Sales Market Share by Company (2020-2025)
 Table 64. Japan Argatroban Revenue by Company (2020-2025) & (US$ Million)
 Table 65. Japan Argatroban Revenue Market Share by Company (2020-2025)
 Table 66. Japan Argatroban Sales by Type (2020-2025) & (g)
 Table 67. Japan Argatroban Sales Market Share by Type (2020-2025)
 Table 68. Japan Argatroban Sales by Application (2020-2025) & (g)
 Table 69. Japan Argatroban Sales Market Share by Application (2020-2025)
 Table 70. Israel Argatroban Sales by Company (2020-2025) & (g)
 Table 71. Israel Argatroban Sales Market Share by Company (2020-2025)
 Table 72. Israel Argatroban Revenue by Company (2020-2025) & (US$ Million)
 Table 73. Israel Argatroban Revenue Market Share by Company (2020-2025)
 Table 74. Israel Argatroban Sales by Type (2020-2025) & (g)
 Table 75. Israel Argatroban Sales Market Share by Type (2020-2025)
 Table 76. Israel Argatroban Sales by Application (2020-2025) & (g)
 Table 77. Israel Argatroban Sales Market Share by Application (2020-2025)
 Table 78. Pfizer, Inc Company Information
 Table 79. Pfizer, Inc Description and Business Overview
 Table 80. Pfizer, Inc Argatroban Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
 Table 81. Pfizer, Inc Argatroban Product
 Table 82. Pfizer, Inc Recent Development
 Table 83. SANDOZ Company Information
 Table 84. SANDOZ Description and Business Overview
 Table 85. SANDOZ Argatroban Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
 Table 86. SANDOZ Argatroban Product
 Table 87. SANDOZ Recent Development
 Table 88. GlaxoSmithKline Plc Company Information
 Table 89. GlaxoSmithKline Plc Description and Business Overview
 Table 90. GlaxoSmithKline Plc Argatroban Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
 Table 91. GlaxoSmithKline Plc Argatroban Product
 Table 92. GlaxoSmithKline Plc Recent Development
 Table 93. fresenius-kabi Company Information
 Table 94. fresenius-kabi Description and Business Overview
 Table 95. fresenius-kabi Argatroban Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
 Table 96. fresenius-kabi Argatroban Product
 Table 97. fresenius-kabi Recent Development
 Table 98. Eagle Pharmaceuticals, Inc Company Information
 Table 99. Eagle Pharmaceuticals, Inc Description and Business Overview
 Table 100. Eagle Pharmaceuticals, Inc Argatroban Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
 Table 101. Eagle Pharmaceuticals, Inc Argatroban Product
 Table 102. Eagle Pharmaceuticals, Inc Recent Development
 Table 103. Mitsubishi Tanabe Pharma Company Information
 Table 104. Mitsubishi Tanabe Pharma Description and Business Overview
 Table 105. Mitsubishi Tanabe Pharma Argatroban Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
 Table 106. Mitsubishi Tanabe Pharma Argatroban Product
 Table 107. Mitsubishi Tanabe Pharma Recent Development
 Table 108. Teva Pharmaceutical Industries Ltd Company Information
 Table 109. Teva Pharmaceutical Industries Ltd Description and Business Overview
 Table 110. Teva Pharmaceutical Industries Ltd Argatroban Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
 Table 111. Teva Pharmaceutical Industries Ltd Argatroban Product
 Table 112. Teva Pharmaceutical Industries Ltd Recent Development
 Table 113. WEST-WARD,INC Company Information
 Table 114. WEST-WARD,INC Description and Business Overview
 Table 115. WEST-WARD,INC Argatroban Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
 Table 116. WEST-WARD,INC Argatroban Product
 Table 117. WEST-WARD,INC Recent Development
 Table 118. Production Base and Market Concentration Rate of Raw Material
 Table 119. Key Suppliers of Raw Materials
 Table 120. Argatroban Distributors List
 Table 121. Argatroban Customers List
 Table 122. Argatroban Market Trends
 Table 123. Argatroban Market Drivers
 Table 124. Argatroban Market Challenges
 Table 125. Argatroban Market Restraints
 Table 126. Research Programs/Design for This Report
 Table 127. Key Data Information from Secondary Sources
 Table 128. Key Data Information from Primary Sources


List of Figures
 Figure 1. Argatroban Product Picture
 Figure 2. Global Argatroban Sales (US$ Million) by Type (2020 & 2024 & 2031)
 Figure 3. Global Argatroban Sales Market Share by Type in 2024 & 2031
 Figure 4. Argatroban Powder Product Picture
 Figure 5. Argatroban Injection Product Picture
 Figure 6. Global Argatroban Sales (US$ Million) by Application (2020 & 2024 & 2031)
 Figure 7. Global Argatroban Sales Market Share by Application in 2024 & 2031
 Figure 8. Heparin-induced Thrombocytopenia (HIT) Examples
 Figure 9. Percutaneous Coronary Intervention Examples
 Figure 10. Cerebral Arterial Thrombosis Examples
 Figure 11. Global Argatroban Sales, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Argatroban Sales Growth Rate (2020-2031) & (US$ Million)
 Figure 13. Global Argatroban Sales (g) Growth Rate (2020-2031)
 Figure 14. Global Argatroban Price Trends Growth Rate (2020-2031) & (USD/g)
 Figure 15. Argatroban Report Years Considered
 Figure 16. Global Market Argatroban Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
 Figure 17. Global Argatroban Revenue Market Share by Region: 2020 VS 2024
 Figure 18. North America Argatroban Revenue (US$ Million) Growth Rate (2020-2031)
 Figure 19. North America Argatroban Sales (g) Growth Rate (2020-2031)
 Figure 20. Europe Argatroban Revenue (US$ Million) Growth Rate (2020-2031)
 Figure 21. Europe Argatroban Sales (g) Growth Rate (2020-2031)
 Figure 22. China Argatroban Revenue (US$ Million) Growth Rate (2020-2031)
 Figure 23. China Argatroban Sales (g) Growth Rate (2020-2031)
 Figure 24. Japan Argatroban Revenue (US$ Million) Growth Rate (2020-2031)
 Figure 25. Japan Argatroban Sales (g) Growth Rate (2020-2031)
 Figure 26. Israel Argatroban Revenue (US$ Million) Growth Rate (2020-2031)
 Figure 27. Israel Argatroban Sales (g) Growth Rate (2020-2031)
 Figure 28. Global Argatroban Revenue Share by Type (2020-2025)
 Figure 29. Global Argatroban Sales Share by Type (2026-2031)
 Figure 30. Global Argatroban Revenue Share by Type (2026-2031)
 Figure 31. Global Argatroban Revenue Share by Application (2020-2025)
 Figure 32. Global Argatroban Revenue Growth Rate by Application in 2020 & 2024
 Figure 33. Global Argatroban Sales Share by Application (2026-2031)
 Figure 34. Global Argatroban Revenue Share by Application (2026-2031)
 Figure 35. Global Argatroban Sales Share by Company (2024)
 Figure 36. Global Argatroban Revenue Share by Company (2024)
 Figure 37. Global 5 Largest Argatroban Players Market Share by Revenue in Argatroban: 2020 & 2024
 Figure 38. Argatroban Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 39. Manufacturing Cost Structure of Argatroban
 Figure 40. Manufacturing Process Analysis of Argatroban
 Figure 41. Argatroban Industrial Chain
 Figure 42. Channels of Distribution (Direct Vs Distribution)
 Figure 43. Distributors Profiles
 Figure 44. Bottom-up and Top-down Approaches for This Report
 Figure 45. Data Triangulation
 Figure 46. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4250

This license allows only one user to access the PDF.
Electronic (PDF)

$6000

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$8000

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Ibuprofen Sodium​ API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30X13296
Fri Mar 21 00:00:00 UTC 2025

Add to Cart

Global Enteric Gelatin Hollow Capsule Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-11U13426
Fri Mar 21 00:00:00 UTC 2025

Add to Cart

Global Argatroban Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

120 Pages
Type: Report
Code: QYRE-Auto-16160
Fri Mar 21 00:00:00 UTC 2025

Add to Cart

Global Contrast Agents Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

120 Pages
Type: Report
Code: QYRE-Auto-10G2665
Fri Mar 21 00:00:00 UTC 2025

Add to Cart